Document is current
Any future updates will be listed below
-
Authors
Gamaarachchi, Hasindu https://orcid.org/0000-0002-9034-9905
Stevanovski, Igor https://orcid.org/0000-0002-7713-1979
Hammond, Jillian M. https://orcid.org/0000-0002-4045-4571
M. Reis, Andre L. https://orcid.org/0000-0002-7300-1157
Rapadas, Melissa https://orcid.org/0000-0002-4900-2838
Jayasooriya, Kavindu
Russell, Tonia
Yeow, Dennis
Hort, Yvonne
Patel, Chirag
Mallett, Andrew J. https://orcid.org/0000-0002-8752-2551
Stackpoole, Elaine
Roman, Lauren
Silver, Luke W. https://orcid.org/0000-0002-1718-5756
Hogg, Carolyn J. https://orcid.org/0000-0002-6328-398X
Streeting, Louise M. https://orcid.org/0000-0002-1663-0010
Bogdanovic, Ozren https://orcid.org/0000-0001-5680-0056
Coelho Rodrigues Noronha, Renata
Santos do Nascimento, Luís Adriano
Lima Cardoso, Adauto
Georges, Arthur
Cheng, Haoyu https://orcid.org/0000-0002-9209-5793
Patel, Hardip R. https://orcid.org/0009-0007-9509-1257
Kumar, Kishore Raj https://orcid.org/0000-0003-3482-6962
Mallawaarachchi, Amali C.
Deveson, Ira W. https://orcid.org/0000-0003-3861-0472
- License Information
-
More Information
Article History
Received: 28 May 2025
Accepted: 15 October 2025
First Online: 24 November 2025
Competing interests
: I.W.D. manages a fee-for-service sequencing facility at the Garvan Institute and is a customer of Oxford Nanopore Technologies and Pacific BioSciences but has no further financial relationship. H.G., A.L.M. and I.W.D. have received travel and accommodation expenses from Oxford Nanopore Technologies. H.R.P. and A.G. have received travel and accommodation expenses from PacBio. The authors declare no other competing financial or nonfinancial interests. The remaining authors declare no competing interests.
